Ozem­pic short­ages have Eu­ro­pean coun­tries ex­plor­ing bans on use of pop­u­lar drug for weight loss

Bel­gium banned the use of No­vo Nordisk’s di­a­betes drug Ozem­pic for weight loss this week, and Ger­many is con­sid­er­ing a sim­i­lar ac­tion amid short­ages of the drug for di­a­bet­ic pa­tients.

Bel­gium an­nounced the ban in the coun­try’s Of­fi­cial Gazette on Tues­day as a roy­al de­cree, Reuters re­port­ed. Bel­gium first an­nounced its plans to in­sti­tute a ban on Ozem­pic for weight loss in Oc­to­ber, with the coun­try’s health min­is­ter say­ing that sim­ply telling doc­tors not to pre­scribe it out­side of its ap­proved use hasn’t worked. The moves fol­low a sim­i­lar one in the UK, where health au­thor­i­ties banned the use of Ozem­pic for weight loss in Ju­ly. We­govy, No­vo’s prod­uct that us­es the same ac­tive in­gre­di­ent, launched for weight loss in the UK in Sep­tem­ber.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER